122 results on '"van Veldhuisen, D. J."'
Search Results
2. Associations of fat and muscle mass indices with incident atrial fibrillation: data of PREVEND
3. Proteomic and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes
4. Obesity, epicardial adipose tissue and left atrial cardiomyopathy in patients with heart failure with preserved ejection fraction: a cardiac MRI based study
5. A pilot study on the effect of advance care planning implementation on healthcare utilisation and satisfaction in patients with advanced heart failure
6. Right‐heart dysfunction in women with congenital heart disease and pre‐eclampsia
7. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)
8. Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
9. Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making
10. Early N-terminal pro-B-type natriuretic peptide is associated with cardiac complications and function during pregnancy in congenital heart disease
11. Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care
12. P566Activated amyloid-beta pathways in patients with atrial fibrillation and heart failure, a pathway analysis in BIOSTAT
13. Tumour biomarkers: association with heart failure outcomes
14. Zorg rondom hartfalen
15. The Role of Vascular Failure in Heart Failure
16. Novel endotypes in heart failure: effects on guideline-directed medical therapy
17. A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
18. 203Impact of mineralocorticoid receptor antagonists on sudden cardiac death in patients with heart failure and left ventricular systolic dysfunction: a meta-analysis of three randomized controlled trials
19. P2294Four targeted therapies and less than four targeted therapies of underlying conditions against conventional therapy in atrial fibrillation - data from the RACE 3 study
20. P910Beware of making dose comparisons for efficacy in post-hoc analyses of achieved dose in up-titrating studies: lessons from the EMPHASIS trial
21. 5223Absolute and functional iron deficiency in heart failure defined and described
22. P1175Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study
23. 54Treating underlying conditions improves quality of life in patients with persistent atrial fibrillation and heart failure - data from the RACE 3 study
24. Awareness of atrial fibrogenesis and natriuretic peptide release
25. Heart failure patients' future expectations and their association with disease severity, quality of life, depressive symptoms and clinical outcomes
26. Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
27. Maternal cardiac function, uteroplacental Doppler flow parameters and pregnancy outcome: a systematic review
28. Arrythythmias in hypertrophic cardiomyopathy: prognostic significance and clinical relevance
29. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
30. Peripartum cardiomyopathy: Euro Observational Research Program
31. Diuretic response in acute heart failure: clinical characteristics and prognostic significance
32. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy
33. Telomere length loss due to smoking and metabolic traits
34. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
35. Contemporary Use of Devices in Heart Failure
36. An Investigation of CYP2D6 Genotype and Response to Metoprolol CR/XL During Dose Titration in Patients With Heart Failure: A MERIT-HF Substudy
37. Prognostic value of NT-pro-C-type natriuretic peptide (NT-proCNP) in heart failure patients with preserved and reduced ejection fraction
38. Restoration of intrathoracic impedance at discharge predicts freedom from re-admission for heart failure
39. Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study
40. Neurohormonal and clinical sex differences in heart failure
41. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial
42. Rate control in atrial fibrillation, insight into the RACE II study
43. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
44. Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?
45. Plasma renin and outcome in the community: data from PREVEND
46. Self-reported versus ‘true’ adherence in heart failure patients: a study using the Medication Event Monitoring System
47. Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapy
48. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
49. Role of inflammation in early atrial fibrillation recurrence
50. The fibrosis marker galectin-3 and outcome in the general population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.